关 于 宁 夏 中 科 生 物 科 技 股 份 有 限 公 司 2025 年 第 五 次 临 时 股 东 会 法 律 意 见 书 大成（银）证字[2025]第 G010 号 北 京 大 成 （ 银 川 ） 律 师 事 务 所 www.dentons.cn 银川市金凤区宁安大街 64 号德丰大厦 25 层（750011） 25/F, Defeng Skyscraper, No.64 Ning'an Street, Jinfeng District, 750011, Yinchuan, China Tel: +86 951-5057676 Fax: +86 951-5057863 关于宁夏中科生物科技股份有限公司 2025 年第五次临时股东会法律意见书 关于宁夏中科生物科技股份有限公司 2025 年第五次临时股东会法律意见书 大成（银）证字[2025]第 G0010 号 致：宁夏中科生物科技股份有限公司 北京大成（银川）律师事务所受宁夏中科生物科技股份有限公司（以下简称 "公司"）的委托，就公司召开2025年第五次临时股东会（以下简称"本次股东 会"）的有关事宜，指派本所郑亚楠、蔡安琪律师（以下简称"本所律师"） ...

证券代码：600165 股票简称：*ST 宁科 公告编号：临 2025-139 宁夏中科生物科技股份有限公司 第十届董事会第一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次董事会应到董事 7 名，实到董事 7 名。 ● 本次董事会共四项议案，经审议全部获得通过。 一、董事会会议召开情况 （四）本次董事会应到董事 7 名，实到董事 7 名。 （五）本次董事会由全体董事共同推举董事符杰先生主持，全体高级管理人 员候选人列席了会议。 二、董事会会议审议情况 与会董事对提交本次会议的四项议案进行了认真审议，表决情况如下： （一）审议《关于拟修订<宁夏中科生物科技股份有限公司董事会战略委员 会实施细则>的议案》 议 案 内 容 详 见 公 司 于 2025 年 12 月 30 日 在 上 海 证 券 交 易 所 网 站 （http://www.sse.com.cn）上披露的《董事会战略委员会实施细则（2025 年 12 月 修订）》。 （一）本次董事会召开符合有关法律、行政法规、部门规章、规范性 ...

关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 近日，赵敬国律师团队代理的投资者诉宁夏中科生物科技股份有限公司（以下简称"宁科生物"或"公 司"）证券虚假陈述案件，部分投资者已拿到赔偿款。上海市信本律师事务所赵敬国律师（执业证号： 13101200410820485）提示，（1）于2022年11月22日-2023年4月5日期间买入且有持仓，无论在2023年4 月6日及之后是否卖出；（2）于2023年4月28日-2024年10月30日期间买入且有持仓，无论在2024年10月 31日及之后是否卖出的受损投资者，或可通过"新浪股民维权平台"自愿登记索赔。（赵敬国律师专栏） 回顾本案，2023年6月1日，公司发布收到《宁夏证监局关于对公司采取出具警示函行政监督管理措施的 决定》的公告，经查，公司存在以下问题：一、未及时披露子公司增资计划进展情况；二、未及时披露 重大诉讼事项。2024年10月30日，公司和实际控制人虞建明先生收到中国证监会下发的《立案告知书》 （编号：证监立案字0342024005号、0342024006号），因涉嫌信息披露违法违规，中国证 ...

Core Viewpoint - China Galaxy Asset is committed to its mission of serving the nation through financial means, actively exploring innovative practices for financial risk resolution and supporting the real economy [1] Group 1: Financial Support and Economic Stability - The capital market plays a crucial role in resource allocation, driving industrial upgrades and fostering new productive forces [1] - The restructuring plan for *ST Ningke in Ningxia Hui Autonomous Region has reached its final stage, marking significant progress in efforts to help the company recover and stabilize the regional economy [1] Group 2: Role of China Galaxy Asset - China Galaxy Asset has been a key player in the rescue efforts, utilizing precise and efficient common benefit bonds to revitalize the company [1] - The actions taken by China Galaxy Asset exemplify the functional role of financial asset management companies in supporting national strategies and stabilizing capital markets [1]

Group 1: Peng Bo Shi (鹏博士) Case - Peng Bo Shi failed to disclose related party transactions as required [8] - Peng Bo Shi did not disclose significant contracts as mandated [8] - From 2012 to 2022, Peng Bo Shi's annual reports contained false records, including a profit inflation of 42,456,137.95 yuan in 2012, which accounted for 17.43% of that year's total profit [6][8] - Annual reports from 2012 to 2015 inflated assets, with the 2016 report inflating assets and profits by 162,000,000 yuan, representing 17.48% of that year's total profit [6][8] - From 2020 to 2022, Peng Bo Shi's annual reports reduced net assets by 196,000,000 yuan, which constituted 21.77%, 14.27%, and 18.51% of the net assets at the end of 2020, 2021, and 2022 respectively [2][6] Group 2: Investor Compensation - Investors who purchased Peng Bo Shi stock between April 12, 2013, and July 18, 2023, and sold or held the stock after July 18, 2023, may initiate claims for compensation [7] - The law firm representing investors in the Peng Bo Shi case has received a mediation agreement, allowing some investors to receive compensation [1][7] Group 3: Ning Ke Biological (宁科生物) Case - Ning Ke Biological's 2022 annual report contained false records, inflating revenue by 76,594,100 yuan and total profit by 77,222,000 yuan, which represented 11.25% and 46.59% of the respective totals [9] - The company failed to timely disclose significant events, including major debts and the freezing of key bank accounts [10][11] - Investors who bought Ning Ke Biological stock between November 22, 2022, and April 6, 2023, and sold or held the stock after April 6, 2023, as well as those who bought between April 28, 2023, and October 31, 2024, may also initiate claims for compensation [11]

宁夏中科生物科技股份有限公司 2025 年第五次临时股东会材料 1 宁夏中科生物科技股份有限公司 2025 年第五次临时股东会议程 一、 宣布会议开幕 二、 宣布到会股东情况 三、 律师确认股东资格合法性 四、 审议表决方法 五、 推选监票人、计票人 六、 审议关于续聘信永中和会计师事务所（特殊普通合伙）为公司 2025 年 度审计机构及内部控制审计机构的议案 七、 审议关于拟增加注册资本暨修订《宁夏中科生物科技股份有限公司章 程》的议案 八、 审议关于拟修订《宁夏中科生物科技股份有限公司高级管理人员年薪 制实施管理办法》的议案 九、 审议关于选举董事的议案 （一）选举刘喜荣先生为宁夏中科生物科技股份有限公司第十届董事会非独 立董事 （二）选举冯战胜先生为宁夏中科生物科技股份有限公司第十届董事会非独 立董事 （三）选举符杰先生为宁夏中科生物科技股份有限公司第十届董事会非独立 董事 （四）选举王炜先生为宁夏中科生物科技股份有限公司第十届董事会非独立 董事 十、 审议关于选举独立董事的议案 （一）选举赵向阳先生为宁夏中科生物科技股份有限公司第十届董事会独立 董事 （二）选举刘辉先生为宁夏中科生物科技股份有限公司第 ...

Group 1: Chemical Sector Performance - The chemical raw materials index increased by 1.62%, while the chemical machinery index decreased by 0.96%, the chemical pharmaceuticals index fell by 1.69%, and the pesticide and fertilizer index rose by 4.21% [1] - The top five rising petrochemical products included folic acid up by 20%, battery-grade lithium carbonate up by 11.08%, nitric acid up by 10.43%, sulfur up by 9.95%, and petroleum coke up by 7.23% [1] - The top five declining petrochemical products were liquid chlorine down by 34%, butadiene down by 7.69%, 2,4-D down by 6.09%, trichloroethylene down by 6.00%, and SBS down by 5.90% [1] Group 2: Oil Sector Performance - The oil processing index rose by 1.39%, while the oil extraction index fell by 0.22%, and the oil trading index increased by 3.44% [1] - International crude oil prices continued to decline, with West Texas Intermediate crude oil futures settling at $56.66 per barrel, down 1.36% from December 12, and Brent crude oil futures settling at $60.47 per barrel, down 1.06% from December 12 [1] Group 3: Capital Market Performance of Listed Chemical Companies - The top five rising listed chemical companies included Sulihua Co., Ltd. up by 30.69%, Xinri Hengli up by 27.48%, Reborn Technology up by 23.25%, Ruihua Tai up by 20.93%, and Shenjian Co., Ltd. up by 20.50% [2] - The top five declining listed chemical companies were Huarong Chemical down by 20.01%, Enjie Co., Ltd. down by 18.36%, Weike Technology down by 13.15%, Jinbantai down by 12.83%, and Xingye Co., Ltd. down by 12.63% [2]

| 证券代码 | 证券简称 | 日涨跌(%) | 笔数 | 环比(%) | | --- | --- | --- | --- | --- | | 600165 | *ST宁科 | 5.01 | 6476 | 6187.38 | | 002788 | 鹭燕医药 | 10.01 | 95978 | 5384.46 | | 603679 | 华体科技 | -9.94 | 76651 | 1860.89 | | 000638 | *ST万方 | 5.02 | 3825 | 1831.82 | | 002231 | *ST奥维 | -2.94 | 8867 | 1375.37 | | 002735 | 王子新材 | 0.00 | 146870 | 1144.34 | | 002204 | 大连重工 | -3.04 | 199859 | 547.95 | | 000551 | 创元科技 | 10.01 | 50479 | 481.09 | | 300276 | 三丰智能 | 8.84 | 68994 | 442.45 | | 601566 | 九牧王 | -3.18 | 132964 | 435.20 | 12月22日每笔 ...

Investment Rating - The report maintains an "Overweight" rating for the basic chemical industry [5] Core Insights - The global semiconductor sales are expected to continue growing in 2025, driven by demand from AI computing, data centers, and smart driving applications. The global semiconductor sales for January to October 2025 are projected to be approximately $612.1 billion, a year-on-year increase of 21.9%, with China's semiconductor sales at about $169.4 billion, up 12.5% [1][22] - The global semiconductor market size is forecasted to reach $700.9 billion in 2025, reflecting an 11.2% year-on-year growth, with the Asia-Pacific region's market size expected to be around $370.6 billion, growing by 9.8% [1][22] - The expansion of wafer production capacity is accelerating, particularly in advanced processes, with a projected compound annual growth rate (CAGR) of 7% from 2024 to 2028 for global 12-inch wafer monthly capacity, expected to reach 11.1 million pieces by 2028 [2][26] - The demand for high-bandwidth memory (HBM) is increasing due to data centers and AI processors, with the global semiconductor materials market expected to reach approximately $70 billion in 2025, a 6% increase year-on-year [3][30] - The advanced process requires higher performance parameters for electronic chemicals, leading to a concentration of industry competition towards leading suppliers capable of meeting these demands [4][32] Summary by Sections Semiconductor Market - AI demand is driving global semiconductor sales growth, with projections for 2025 indicating a significant increase in both global and Chinese markets [1][22] - The semiconductor market is expected to grow to $700.9 billion in 2025, with a further increase to $760.7 billion in 2026 [1][22] Wafer Production Capacity - The global semiconductor wafer production capacity is set to expand significantly, particularly in advanced processes, with a CAGR of 14% for 7nm and below processes from 2024 to 2028 [2][26] Semiconductor Materials - The global semiconductor materials market is projected to grow to $70 billion in 2025, with a notable increase in China's market size to approximately 174.1 billion yuan, reflecting a 21.1% year-on-year growth [3][30] Electronic Chemicals - The advanced semiconductor processes require higher purity and stability in electronic chemicals, leading to a competitive landscape favoring top suppliers with technological and scale advantages [4][32] Investment Recommendations - The report suggests focusing on leading companies in semiconductor materials, particularly those with strong technological capabilities and deep ties to downstream wafer manufacturers [34]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600165 股票简称：*ST宁科（维权） 公告编号：临2025-137 宁夏中科生物科技股份有限公司 股票交易风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容及风险提示： ● 宁夏中科生物科技股份有限公司（以下简称：公司）被法院裁定终止重整程序，进入重整计划执行阶 段。根据《中华人民共和国企业破产法》的相关规定，在重整计划执行期间，如公司不执行或不能执行 重整计划，将存在被法院宣告破产的风险。如果公司被宣告破产，公司将被实施破产清算，根据《上海 证券交易所股票上市规则》第9.4.15条的规定，公司股票将面临被终止上市的风险。 ● 宁夏中科生物新材料有限公司（以下简称：中科新材）于2024年2月7日进入停产状态后，根据《上海 证券交易所股票上市规则》的相关规定，公司股票自2024年4月8日起已被上海证券交易所（以下简称： 上交所）实施其他风险警示。虽然中科新材近期已经实现复工复产，但能否实现可持续的正常生产经营 能力，仍有不确定性。 司被宣告破产 ...